BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34602623)

  • 1. Pharmacist Intervention to Improve Medication Adherence in Patients with Acute Coronary Syndrome: The PRIMA-ACS Study.
    Neville HL; Mann K; Killen J; Callaghan M
    Can J Hosp Pharm; 2021; 74(4):350-360. PubMed ID: 34602623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
    Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
    JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study.
    El Hajj MS; Kaddoura R; Abu Yousef SEA; Orabi B; Awaisu A; AlYafei S; Shami R; Mahfoud ZR
    Int J Clin Pharm; 2023 Jun; 45(3):630-640. PubMed ID: 36795303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist-Led Discharge Medication Counseling and its Corresponding Impact on Medication Adherence and Hospital Readmission Rates.
    Cunningham S; Kinsey JD
    Innov Pharm; 2020; 11(3):. PubMed ID: 34007627
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacist-Led Intervention to Enhance Medication Adherence in Patients With Acute Coronary Syndrome in Vietnam: A Randomized Controlled Trial.
    Nguyen T; Nguyen TH; Nguyen PT; Tran HT; Nguyen NV; Nguyen HQ; Ha BN; Pham TT; Taxis K
    Front Pharmacol; 2018; 9():656. PubMed ID: 29977205
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of a clinical pharmacist on optimising the quality use of medicines according to the acute coronary syndrome (ACS) secondary prevention guidelines and medication adherence following discharge in patients with ACS in Sri Lanka: a prospective non-randomised controlled trial study protocol.
    Bagyawantha NMY; Coombes ID; Gawarammana I; Fahim M
    BMJ Open; 2023 Feb; 13(2):e059413. PubMed ID: 36759028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review.
    El Hajj MS; Jaam MJ; Awaisu A
    Res Social Adm Pharm; 2018 Jun; 14(6):507-520. PubMed ID: 28641999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.
    Zidan A; Awaisu A; Kheir N; Mahfoud Z; Kaddoura R; AlYafei S; El Hajj MS
    BMJ Open; 2016 Nov; 6(11):e012141. PubMed ID: 27864247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of eHealth Technologies on Medication Adherence in Patients With Acute Coronary Syndrome: Systematic Review and Meta-Analysis.
    Bhagavathula AS; Aldhaleei WA; Atey TM; Assefa S; Tesfaye W
    JMIR Cardio; 2023 Dec; 7():e52697. PubMed ID: 38113072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study.
    Livori AC; Pol D; Levkovich B; Oqueli E
    Int J Clin Pharm; 2023 Jun; 45(3):722-730. PubMed ID: 36940081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of Clinical Pharmacist Intervention on the Secondary Prevention of Coronary Heart Disease: A Randomized Controlled Clinical Study.
    Xu H; Zou J; Ye X; Han J; Gao L; Luo S; Wang J; Huang C; Yan X; Dai H
    Front Pharmacol; 2019; 10():1112. PubMed ID: 31649528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in Medication Adherence Between Patients Prescribed a 30-Day Versus 90-Day Supply After Acute Myocardial Infarction.
    Rymer JA; Fonseca E; Bhandary DD; Kumar D; Khan ND; Wang TY
    J Am Heart Assoc; 2021 Jan; 10(1):e016215. PubMed ID: 33342227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.
    Mathews R; Wang W; Kaltenbach LA; Thomas L; Shah RU; Ali M; Peterson ED; Wang TY
    Circulation; 2018 May; 137(20):2128-2138. PubMed ID: 29386204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.
    Schnipper JL; Roumie CL; Cawthon C; Businger A; Dalal AK; Mugalla I; Eden S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Johnson DC; Labonville S; Gregory D; Kripalani S;
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):212-9. PubMed ID: 20233982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-centered adherence intervention after acute coronary syndrome hospitalization.
    Lambert-Kerzner A; Del Giacco EJ; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Davis R; Mun H; Weaver J; Barnett C; Radcliff T; Hubbard A; Bosket KD; Carey E; Virchow A; Mihalko-Corbitt R; Kaufman A; Marchant-Miros K; Ho PM;
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):571-6. PubMed ID: 22811499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
    Kalista T; Lemay V; Cohen L
    J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.